Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleApatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.AuthorsDuan, Jian-Chun; Wang, Zhi-Jie; Lin, Lin; Li, Jun-Ling; Wang, Yan; Bai, Hua; Hu, Xing-Sheng; Liu, Yu-Tao; Hao, Xue-Zhi; Wang, Hong-Yu; Wan, Rui; Wang, Xin; Wang, JiePublicationInvestigational New Drugs, 2019, Vol 37, Issue 4, p731ISSN0167-6997Publication typeArticleDOI10.1007/s10637-019-00735-1